Related Experiment Video
Updated: Jul 18, 2026
12:39
Chip-based Three-dimensional Cell Culture in Perfused Micro-bioreactors
Published on: May 21, 2008
A microfluidic platform for 3-dimensional cell culture and cell-based assays
Minseok S Kim1, Ju Hun Yeon, Je-Kyun Park
1Department of BioSystems, Korea Advanced Institute of Science and Technology (KAIST), 373-1 Guseong-dong, Yuseong-gu, Daejeon 305-701, Republic of Korea.
Biomedical Microdevices
|November 15, 2006
Summary
This study introduces a novel microfluidic platform using peptide hydrogel for 3D cell culture and in situ assays. It enables in vivo-like environments for reliable cell-based screening and toxicity testing.
Area of Science:
- Biotechnology
- Microfluidics
- Biomaterials
Background:
- Developing in vivo-like microenvironments is crucial for accurate cell-based assays.
- Existing methods often lack the complexity to mimic native tissue conditions.
- Peptide hydrogels offer promising biocompatibility and structural support for cell culture.
Purpose of the Study:
- To develop and validate a novel microfluidic platform utilizing peptide hydrogel for 3D cell culture.
- To create a biocompatible microenvironment for human hepatocellular carcinoma cells (HepG2).
- To enable in situ cell-based assays, including toxicity testing and dose-response studies.
Main Methods:
- Comparison of different peptide hydrogels (Collagen composite, OPLA, Puramatrix) for HepG2 cell culture.
- 3D immobilization and encapsulation of HepG2 cells within Puramatrix hydrogel in a microfluidic device.
- Culturing cells in the microfluidic device and comparing them to conventional petri dish cultures.
- Generating linear concentration gradients of reagents for toxicity assessments using Triton X-100.
Main Results:
- Puramatrix was selected as the optimal peptide hydrogel for HepG2 cell culture based on albumin secretion.
- HepG2 cells cultured in the microfluidic peptide scaffold exhibited 3D morphology and maintained albumin secretion.
- The microfluidic device successfully generated linear concentration gradients, enabling dose-dependent toxicity assessments.
- A clear correlation was observed between toxicant concentration gradient and the extent of cell death.
Conclusions:
- The developed microfluidic platform provides an in vivo-like 3D microenvironment for cell culture.
- This platform supports reliable cell-based screening, including cytotoxicity tests and dose-response assays.
- The system has significant potential for advancing drug discovery and toxicological evaluations.
